Propanc Biopharma, Inc. (OTCMKTS:PPCB) Short Interest Up 100.0% in March

Propanc Biopharma, Inc. (OTCMKTS:PPCB) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 200 shares, an increase of 100.0% from the February 28th total of 100 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 400 shares, the short-interest ratio is currently 0.5 days.

Propanc Biopharma Trading Down 7.6 %

PPCB stock traded down $0.43 during midday trading on Friday, reaching $5.25. The stock had a trading volume of 116 shares, compared to its average volume of 415. The company’s fifty day simple moving average is $6.64 and its 200 day simple moving average is $2.31. Propanc Biopharma has a 52-week low of $2.76 and a 52-week high of $222.00.

About Propanc Biopharma

Propanc Biopharma, Inc, a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.